Chronic Obstructive Pulmonary Disease (COPD) is a common disease associated with significant morbidity and mortality that is both preventable and treatable.
Consideration of three different composite indices of arterial oxygenation changes during exercise does not add prognostic value to that of the 6MWD in patients with PAH.
La nueva normativa GOLD 2023, el slide set y la pocket guide ya están disponibles gratis para descargar
Vídeo de la Presentación de las Novedades Gold 2023 del 23 de Noviembre de 2022, de 17 a 19h, presentado y moderado por El Dr. Alvar Agustí.
Recent evidence highlights the importance of optimal lung development during childhood for health throughout life. Objectives: To explore the plasticity of individual lung function states during childhood.
COPD is a complex and heterogeneous disease characterized by chronic airway inflammation. The latter may alter airway antimicrobial defense systems and therefore favor the colonization of the bronchial mucosa by potentially pathogenic microorganisms.
Participa en la reunión mixta «Novedades GOLD 2023» el próximo 23 de Noviembre de 2022. Con la participación de: Alvar Agustí, B. Cosio, JL Izquierdo, JL Lopez-Campos, M. Miravitlles, JJ Soler-Catalunya
Alvar Agustí, Chairman del GOLD Board of Directors, participa en la reunión internacional en Filadelfia (EEUU) el 16 de Noviembre de 2022, para presentar la nueva guía 2023 sobre la enfermedad pulmonar obstructiva crónica (EPOC).
The European Respiratory Journal is voluntarily reviewed. We are most grateful for the hard work and dedication of all those who reviewed articles for the ERJ in 2022.
Evidence from clinical studies indicates that the inhaled corticosteroids (ICS) routinely taken for asthma and COPD could have had a protective role in preventing severe COVID-19 and, therefore, may be a promising treatment for COVID-19.
